Checkmate Pharmaceuticals Inc (CMPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,498 | 50,695 | 53,514 | 63,130 | 39,147 |
| Marketable Securities | 20,555 | 20,192 | 27,350 | 22,240 | 46,684 |
| TOTAL | $62,110 | $73,962 | $88,671 | $91,074 | $94,060 |
| Non-Current Assets | |||||
| PPE Net | 735 | 777 | 668 | 367 | N/A |
| Investments And Advances | 0 | 0 | 0 | 10,240 | 25,647 |
| Other Non-Current Assets | 4,099 | 4,099 | 0 | 0 | 0 |
| TOTAL | $4,834 | $4,876 | $668 | $10,607 | $25,647 |
| Total Assets | $66,944 | $78,838 | $89,339 | $101,681 | $119,707 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,608 | 3,385 | 2,521 | 2,198 | 2,086 |
| Accrued Expenses | 8,334 | 5,994 | 5,291 | 4,504 | 5,225 |
| TOTAL | $11,942 | $9,379 | $7,812 | $6,702 | $7,311 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $11,942 | $9,379 | $7,812 | $6,702 | $7,311 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,038 | 21,631 | 21,631 | 21,626 | 21,626 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -217,343 | -201,476 | -188,135 | -173,169 | -154,199 |
| Other shareholders' equity | -57 | -14 | -2 | -33 | -83 |
| TOTAL | $55,002 | $69,459 | $81,527 | $94,979 | $112,396 |
| Total Liabilities And Equity | $66,944 | $78,838 | $89,339 | $101,681 | $119,707 |